The world urgently needs new treatments, as well as improved use and stewardship of existing antibiotics in humans and animals, to tackle the rising global threat of drug resistance. CARB-X is funding the best science around the world to accelerate the development of new antibiotics, vaccines, diagnostics and other life-saving products. CARB-X and the innovation it accelerates are an essential part of the solution.
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is a global non-profit partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria. With up to US$500 million to invest, CARB-X funds the best science from around the world. Project should focus on early development of new antibiotics, vaccines, rapid diagnostics and other products to prevent, diagnose and treat life-threatening bacterial infections.
Program has reached funding limit. There will be no new deadlines announced.
To get free funding updates, subscribe to Catalyze Alerts.
More about CARB-X
CARB-X is led by Boston University and is funded by the US Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR), the Wellcome Trust, a global charity based in the UK working to improve health globally, Germany’s Federal Ministry of Education and Research (BMBF), the UK Government’s Global Antimicrobial Resistance Innovation Fund (UK GAMRIF), the Bill & Melinda Gates Foundation, the world’s largest foundation dedicated to improving the quality of life for individuals around the world, and receives in-kind support from National Institute of Allergy and Infectious Diseases (NIAID), part of the US National Institutes of Health (NIH).
Visit the CARB-X website for more information
Get funding, make impact
Whether you’re an academic or entrepreneur, we craft the roadmap you need to take on the challenges present in finding funding and reaching your market. With over 10 years of experience, we are your gateway to European funding, and beyond.
- Fund. What if funding wasn’t a barrier to innovation? We guide you through the way of finding and obtaining funds.
- Grow. What if your journey was clear? Get the best support for your grant journey.
- Manage. What if you only had to focus on R&D? We provide the support you need to get your innovation on the market.